These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19905885)

  • 1. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
    Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT
    Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
    Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
    Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
    Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
    Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
    Rosenstock J; Cefalu WT; Hollander PA; Belanger A; Eliaschewitz FG; Gross JL; Klioze SS; St Aubin LB; Foyt H; Ogawa M; Duggan WT
    Diabetes Care; 2008 Sep; 31(9):1723-8. PubMed ID: 18535196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
    Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
    Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus.
    Mendivil CO; Teeter JG; Finch GL; Schwartz PF; Riese RJ; Brain JD
    Diabetes Technol Ther; 2012 Jan; 14(1):50-8. PubMed ID: 21875362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; BĂ©langer A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes.
    Hompesch M; Kollmeier A; Rave K; Heinemann L; Mitnick M; Davies S; Strack T
    Diabetes Technol Ther; 2009 May; 11(5):307-13. PubMed ID: 19537357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial.
    White NH; Quattrin T; St Aubin LB; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):555-68. PubMed ID: 18717242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function changes related to acute and chronic administration of inhaled insulin.
    Hegewald M; Crapo RO; Jensen RL
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S93-S101. PubMed ID: 17563309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Inhaled Human Insulin (Exu hera
    White NH; Quattrin T; Aubin LBS; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2020 Oct; 21(6):555-568. PubMed ID: 33600687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
    Brain JD
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S14-8. PubMed ID: 16135134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes.
    Liu MC; Riese RJ; Van Gundy K; Norwood P; Sullivan BE; Schwartz PF; Teeter JG
    Eur Respir J; 2008 Jul; 32(1):180-8. PubMed ID: 18321936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled human insulin.
    Strack TR
    Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.